Douglas J. Gentilcore

Business address
C/O Y Mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York, NY, 10169
Top holdings (ownership)
YMAB
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Douglas J. Gentilcore has filed 3 SEC EDGAR filings since 17 Jan 2025

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 18 Sep 2025 16 Sep 2025 001-38650
4 Open Document Open Filing 22 Jan 2025 17 Jan 2025 001-38650
3 Open Document Open Filing 17 Jan 2025 07 Jan 2025 001-38650